Pricing Log in Create free account

MBody AI Ltd. (MBAI) vs MedX Health Corp. (MDXHF)

MBody AI Ltd. and MedX Health Corp. are both Diagnostics & Research companies. MedX Health Corp. is the larger, with a market value of $103.2M against $47.4M — 2.2× the size. MBody AI Ltd. has the higher net margin (0.00% vs −1,087.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, MBody AI Ltd. leads on 7 and MedX Health Corp. on 5.

Valuation

Metric MBAI MDXHF Diagnostics & Research median
P/E n/m n/m 35.56
P/S n/m 23.85 4.37
P/B 0.61 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales n/m 29.40 5.51
Earnings yield (763.41%) (46.67%) (1.89%)
Free cash flow yield (565.34%) (52.97%) (0.15%)

Profitability

Metric MBAI MDXHF Diagnostics & Research median
Gross margin 0.00% (1.89%) 50.89%
Operating margin 0.00% (753.38%) (8.57%)
Net margin 0.00% (1,087.83%) (6.37%)
Free cash flow margin 0.00% (655.93%) 0.00%
Return on equity 0.00% 63.71% (2.92%)
Return on assets 0.00% (840.71%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MBAI MDXHF Diagnostics & Research median
Revenue growth (TTM) — 20.12% 7.69%
EPS growth (last fiscal year) 115.35% (52.00%) 25.92%
Revenue growth, 5-year CAGR — (55.05%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBAI MDXHF Diagnostics & Research median
Debt to equity 0.00 (0.30) 0.11
Current ratio 0.71 0.02 2.02
Net debt to EBITDA 0.09 (0.40) 0.70

Dividend

Metric MBAI MDXHF Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric MBAI MDXHF Diagnostics & Research median
Market cap 47.41m 103.16m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack